Medicamen Biotech Limited - Company Profile

Q: Who are the current directors of Medicamen Biotech Limited?

The current directors of Medicamen Biotech Limited are Vimal Kumar Shrawat, Harish Pande, Shaival Saurabh, Rahul Bishnoi, Suresh Kumar Singh, Arun Kumar, Rajesh Madan, Ravi Kumar Bansal, Sumita Dwivedi, Rajesh Madan, Parul Choudhary, Sham Goel, Sanjay Bansal, Sangeeta Bishnoi, Ashwani Kumar Sharma, Chandan Kumar.

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1993.

1993 New Delhi, Delhi, India Active

Last Updated: December 29, 2025

Access Report

About Medicamen Biotech Limited

Medicamen Biotech Limited, a active public limited company, was established on 22 December 1993 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L74899DL1993PLC056594. Registered under ROC Roc Delhi. it is listed on BSE: 531146 and NSE: MEDICAMEQ. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹13.56 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹174.69 Cr and a net worth of ₹209.21 Cr. Employing 314 professional, Its leadership includes Vimal Kumar Shrawat (Director), Harish Pande (Director), Shaival Saurabh (Director). Past directors included Vimal Kumar Shrawat, Piyush Kumar Gupta, Bhabagrahi Pradhan. It holds ₹65.90 Cr open charges and ₹52.09 Cr settled loans. Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, Delhi, 110019.

Company Details

CIN/LLPIN
L74899DL1993PLC056594
Registration Number
056594
Incorporation Date
22 December 1993
Authorized Capital
₹15.00 Cr
Paid-Up Capital
₹13.56 Cr
ROC Code
Roc Delhi
Listing Status
Listed (BSE: 531146, NSE: MEDICAMEQ)
Company Status
Active

Key Metrics

Authorised Capital ₹ 15.00 Cr as on 29-12-2025
Paid Up Capital ₹ 13.56 Cr as on 29-12-2025
Company Age 32 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 65.90 Cr as on 29-12-2025
Satisfied Charges ₹ 52.09 Cr as on 29-12-2025
Revenue Growth **** 24.47% (FY 2024)
Profit Growth **** -11.36% (FY 2024)
Ebitda **** 7.55% (FY 2024)
Net Worth 7.95% (FY 2024)
Total Assets **** 6.30% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Medicamen Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Medicamen Biotech Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vimal Kumar Shrawat	Director	11 Feb 2019	Current
Harish Pande	Director	31 Dec 2015	Current
Shaival Saurabh	Director	12 Aug 2025	Current
Rahul Bishnoi	Director	31 Dec 2015	Current
Suresh Kumar Singh	Director	31 Dec 2015	Current
Arun Kumar	Director	27 Feb 2016	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	25 Sep 2019	Past
Pramod Abcsdd	Whole-Time Director	11 Aug 2012	Past
Pramod Abcsdd	Company Secretary	31 May 2007	Past
Pramod Abcsdd	Whole-Time Director	26 Sep 2013	Past
Pramod Abcsdd	Additional Director	27 Feb 2016	Past
Pramod Abcsdd	Additional Director	25 Sep 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medicamen Biotech.

Medicamen Biotech Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 24.47% increase. The company also saw a substantial fall in profitability, with a 11.36% decrease in profit. The company's net worth moved up by a moderate rise of 7.95%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

24.47%

*******

Revenue from Operations

*******

25.02%

*******

Total Assets

*******

6.30%

*******

Profit or Loss

*******

-11.36%

*******

Net Worth

*******

7.95%

*******

EBITDA

*******

7.55%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medicamen Biotech?

In 2024, Medicamen Biotech had a promoter holding of 42.99% and a public holding of 57.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹658,975,000.00

Satisfied Charges

₹520,940,000.00

Charges Breakdown by Lending Institutions

Others : 45.55 Cr
Citi Bank N.A. : 20.00 Cr
Hdfc Bank Limited : 0.35 Cr

Latest Charge Details

Date	Lender	Amount	Status
28 Mar 2025	Others	₹9.00 Cr	Open
21 Mar 2025	Others	₹1.17 Cr	Open
10 May 2023	Hdfc Bank Limited	₹3.50 M	Open
19 Mar 2021	Citi Bank N.A.	₹20.00 Cr	Open
30 Jan 2021	Others	₹1.20 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Medicamen Biotech?

Medicamen Biotech has a workforce of 314 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Medicamen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicamen Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medicamen Biotech

Recent Activity within the Organization

Annual General Meeting

Medicamen Biotech Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was recorded as a recent event.
26 Sep 2025
Director Appointment

Shaival Saurabh was appointed as a Director was appointed as a Director on 12 Aug 2025 & has been associated with this company since 6 months 9 days . was recorded as a recent event.
12 Aug 2025
Director Appointment

Progress on Sham Goel was appointed as a Director was appointed as a Director on 12 Aug 2025 & has been associated with this company since 6 months 9 days . was documented.
12 Aug 2025
Charges

Progress on A charge with Others of Rs. 9.00 Cr registered on 28 Mar 2025 with Charge ID 101091431 was modified on 30 Jul 2025. was documented.
30 Jul 2025
Charges

The activity A charge with Citi Bank N.A. of Rs. 20.00 Cr registered on 19 Mar 2021 with Charge ID 100449354 was modified on 23 Jun 2025. was completed.
23 Jun 2025
Charges

A charge registered on 25 Nov 2019 via Charge ID 100303030 with Others was fully satisfied on 15 May 2025. was recorded as a recent event.
15 May 2025

Explore recent activity and updates - View Recent Activity